Kenvue Inc (KVUE): P/S Multiple

Brandmark of Kenvue Health (KVUE)

The price-to-sales ratio for Kenvue Inc. (KVUE) reflects the business valuation dynamics, where 2.40 describes the current status of the metric. The company's stability relies on global manufacturing plants and demand for essential consumer goods. Well-known brands and pharmacy chains create barriers to entry for newcomers under FDA supervision. A broad portfolio of hygiene products ensures ultra-reliable revenue diversification worldwide.

KVUE Kenvue Inc Price-to-Revenue Ratio (02/21/2024 - 11/13/2026)

Kenvue Corp (KVUE) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart kenvue.com|KVUE - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Kenvue Corp|KVUE - Enterprise Value
- balance sheet equity data:
Net Asset Value per Share Kenvue|KVUE - Company Book Value|Capitalization to Book Value Ratio kenvue.com|KVUE - Cumulative Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Kenvue Inc.|KVUE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Kenvue Health|KVUE - Company Aggregate Debts|Debts to Book Value Kenvue Corp|KVUE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Kenvue|Interim Coverage Ratio kenvue.com
- earnings and multiples data:
KVUE - Company Net Income|Net Profit Forecast Kenvue Inc.|KVUE - P/E Multiple|Projected Price to Earnings Kenvue Inc|KVUE - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Kenvue Corp|KVUE - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Kenvue|KVUE - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months kenvue.com|KVUE - Net earnings per share growth this year|Earnings growth forecast for next year Kenvue Inc.
- total revenue and sales volume data:
KVUE - Revenue and Sales Volume|Company Expected Sales Volume kenvue.com|KVUE - Price-to-Revenue Ratio|Future Price to Revenue Kenvue Corp
General company analysis:KVUE - kenvue.com
Product sample of Kenvue Corp

Steady demand for Kenvue Inc. (KVUE) over-the-counter drugs allows the company to index prices in line with inflation, making the market valuation based on sales volume a key indicator of business resilience. By analyzing the price-to-sales ratio, an investor determines how many market dollars are attributed to each unit of revenue, identifying phases of asset overvaluation or consolidation to optimize the entry point.

Who Kenvue Inc. competes with

HLN (haleon.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Verona Pharma VRNA|P/S Multiple Jyong Biotech Limited MENS|Ligand Pharma - P/S Multiple|Price to Sales Amneal Corp|Perrigo Company plc (PRGO) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio ALVO|Market Cap to Revenue LQDA|Price-to-Revenue Ratio GLPG|Market Cap to Revenue ANIP (ANI Pharma)|P/S Multiple Afrezza (MNKD)|P/S Multiple AMPH (Amphastar Pharmaceuticals)|pacira.com (PCRX) - Price to Sales|SPRY: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio TBPH (Theravance Biopharma Inc)|AQST: P/S Multiple|SCPH - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Tectonic Therapeutic Inc.|Market Cap to Revenue Ratio TNXP (tonixpharma.com)|P/S Multiple SXTC|Market Cap to Revenue eupraxiapharma.com EPRX|BioHarvest - Market Cap to Revenue|Price-to-Revenue Coefficient Invizyne (EXOZ)|ORMP - Price-to-Revenue Ratio|ENTX - P/S Multiple|HYFT (MindWalk Holdings Inc.) - Market Cap to Revenue|ABVC (ABVC BioPharma Inc.) - Price-to-Revenue Ratio|Market Cap to Revenue CPIX|P/S Multiple Quantum BioPharma Corp|P/S Multiple FGEN|TELO - Price to Sales|Price-to-Revenue Ratio Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Price-to-Sales Ratio|Rallybio Corp. - P/S Multiple|Market Capitalization-to-Revenue Ratio LEXX (Lexaria Bioscience)|PULM: P/S Multiple|Pheton Holdings (PTHL) - P/S Multiple|Price-to-Revenue Ratio Aptorum Group Ltd|LYRA: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Impact BioMedical (IBO)|Market Cap to Revenue tnfpharma.com TNFA|P/S Multiple YCBD (cbdMD)|P/S Multiple painreform.com PRFX|CYTO: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio LIPO (Lipella Pharmaceuticals Inc)|Optinose (OPTN) - Price-to-Revenue Ratio|Price to Sales Pieris Pharma (PIRS)|Market Cap to Revenue PROC|PTPI (petrospharma.com) - Market Cap to Sales Volume|P/S Multiple QLI|SLRN (Acelyrin Inc.) - Market Capitalization-to-Revenue Ratio|P/S Multiple TFFP (TFF Pharma)